title: Erratum to: Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma.
authors.affiliation: Department of Medicine, Division of Hematology-Oncology, University of California Los Angeles (UCLA), 11-934 Factor Building, Los Angeles, CA, USA.
authors.forename: Deborah J L
authors.initials: DJ
authors.lastname: Wong
authors.affiliation: Department of Medicine, Division of Hematology-Oncology, University of California Los Angeles (UCLA), 11-934 Factor Building, Los Angeles, CA, USA.|Universitat Autonoma de Barcelona, UAB, Barcelona, Spain.
authors.forename: Lidia
authors.initials: L
authors.lastname: Robert
authors.affiliation: Department of Medicine, Division of Hematology-Oncology, University of California Los Angeles (UCLA), 11-934 Factor Building, Los Angeles, CA, USA.
authors.forename: Mohammad S
authors.initials: MS
authors.lastname: Atefi
authors.affiliation: Department of Medicine, Division of Hematology-Oncology, University of California Los Angeles (UCLA), 11-934 Factor Building, Los Angeles, CA, USA.
authors.forename: Amanda
authors.initials: A
authors.lastname: Lassen
authors.affiliation: Department of Medicine, Division of Hematology-Oncology, University of California Los Angeles (UCLA), 11-934 Factor Building, Los Angeles, CA, USA.|University of Applied Sciences, Vienna, Austria.
authors.forename: Geetha
authors.initials: G
authors.lastname: Avarappatt
authors.affiliation: Department of Medicine, Division of Hematology-Oncology, University of California Los Angeles (UCLA), 11-934 Factor Building, Los Angeles, CA, USA.
authors.forename: Michael
authors.initials: M
authors.lastname: Cerniglia
authors.affiliation: Department of Medicine, Division of Hematology-Oncology, University of California Los Angeles (UCLA), 11-934 Factor Building, Los Angeles, CA, USA.
authors.forename: Earl
authors.initials: E
authors.lastname: Avramis
authors.affiliation: Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, CA, USA.
authors.forename: Jennifer
authors.initials: J
authors.lastname: Tsoi
authors.affiliation: Department of Medicine, Division of Hematology-Oncology, University of California Los Angeles (UCLA), 11-934 Factor Building, Los Angeles, CA, USA.
authors.forename: David
authors.initials: D
authors.lastname: Foulad
authors.affiliation: Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, CA, USA.
authors.forename: Thomas G
authors.initials: TG
authors.lastname: Graeber
authors.affiliation: Department of Surgery, Division of Surgical-Oncology, UCLA, Los Angeles, CA, USA.|Jonsson Comprehensive Cancer Center at UCLA, 10833 Le Conte Avenue, Los Angeles, CA, 90095-1782, USA.
authors.forename: Begonya
authors.initials: B
authors.lastname: Comin-Anduix
authors.affiliation: Discovery Oncology Merck Research Laboratories, Merck Research Laboratories, Boston, Massachusetts, USA.
authors.forename: Ahmed
authors.initials: A
authors.lastname: Samatar
authors.affiliation: Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, CA, USA.|Jonsson Comprehensive Cancer Center at UCLA, 10833 Le Conte Avenue, Los Angeles, CA, 90095-1782, USA.|Department of Medicine, Division of Dermatology, UCLA, Los Angeles, California, USA.
authors.forename: Roger S
authors.initials: RS
authors.lastname: Lo
authors.affiliation: Department of Medicine, Division of Hematology-Oncology, University of California Los Angeles (UCLA), 11-934 Factor Building, Los Angeles, CA, USA. aribas@mednet.ucla.edu.|Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, CA, USA. aribas@mednet.ucla.edu.|Department of Surgery, Division of Surgical-Oncology, UCLA, Los Angeles, CA, USA. aribas@mednet.ucla.edu.|Jonsson Comprehensive Cancer Center at UCLA, 10833 Le Conte Avenue, Los Angeles, CA, 90095-1782, USA. aribas@mednet.ucla.edu.
authors.forename: Antoni
authors.initials: A
authors.lastname: Ribas